South Korea Gabapentin Market Size & Outlook, 2025-2030
Related Markets
South Korea gabapentin market highlights
- The South Korea gabapentin market generated a revenue of USD 31.5 million in 2024 and is expected to reach USD 46.0 million by 2030.
- The South Korea market is expected to grow at a CAGR of 6.5% from 2025 to 2030.
- In terms of segment, capsule was the largest revenue generating dosage form in 2024.
- Oral Solution is the most lucrative dosage form segment registering the fastest growth during the forecast period.
Gabapentin market data book summary
| Market revenue in 2024 | USD 31.5 million |
| Market revenue in 2030 | USD 46.0 million |
| Growth rate | 6.5% (CAGR from 2025 to 2030) |
| Largest segment | Capsule |
| Fastest growing segment | Oral Solution |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tablet, Capsule, Oral Solution |
| Key market players worldwide | Zydus Lifesciences, Glenmark Pharmaceuticals, Sun Pharmaceutical Industries, Ascendis Pharma, Apotex Inc., Teva Pharmaceutical Industries Ltd, Aurobindo Pharma, Amneal Pharmaceuticals, Cipla Ltd DR, Assertio Holdings Inc, Arbor Pharmaceuticals, Pfizer Inc |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.4% of the global gabapentin market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China gabapentin market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 104.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Gabapentin Market Scope
Gabapentin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Ascendis Pharma | View profile | 501-1000 | Palo Alto, California, United States, North America | http://ascendispharma.com |
| Assertio Holdings Inc | View profile | 30 | 100 South Saunders Road, Suite 300, Lake Forest, IL, United States, 60045 | https://www.assertiotx.com |
| Glenmark Pharmaceuticals | View profile | 10001+ | Andheri, Maharashtra, India, Asia | http://www.glenmarkpharma.com |
| Apotex Inc. | View profile | 10001+ | Toronto, Ontario, Canada, North America | http://www.apotex.com |
| Amneal Pharmaceuticals | View profile | 5001-10000 | Bridgewater, New Jersey, United States, North America | http://amneal.com/ |
| Arbor Pharmaceuticals | View profile | 501-1000 | Atlanta, Georgia, United States, North America | http://www.arborpharma.com |
| Zydus Lifesciences | View profile | 10001+ | Ahmedabad, Gujarat, India, Asia | https://zyduslife.com/ |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Aurobindo Pharma | View profile | 10001+ | Hyderabad, Andhra Pradesh, India, Asia | http://aurobindo.com |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
South Korea gabapentin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gabapentin market will help companies and investors design strategic landscapes.
Capsule was the largest segment with a revenue share of 59.68% in 2024. Horizon Databook has segmented the South Korea gabapentin market based on tablet, capsule, oral solution covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to South Korea gabapentin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea gabapentin market databook
-
Our clientele includes a mix of gabapentin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea gabapentin market , including forecasts for subscribers. This country databook contains high-level insights into South Korea gabapentin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea gabapentin market size, by dosage form, 2018-2030 (US$M)
South Korea Gabapentin Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
